CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
Go back to CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications| CVS Caremark Corp. (NYSE: CVS) | Delayed: 88.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.84 | 52 Week High | $106.67 | |||
| Open | $88.84 | 52 Week Low | $69.30 | |||
| Day High | $88.84 | P/E | 23.69 | |||
| Day Low | $88.84 | EPS | $3.75 | |||
| Volume | 1,095 | |||||
